Exposure via breast milk refers to the potential transfer of substances — including medications, chemicals, infectious agents, and environmental toxins — from a breastfeeding mother to her infant through breast milk. Understanding when and how such exposures occur is essential for protecting infant health while supporting the many benefits of breastfeeding.

Introduction: Who Should Undergo Diagnostics and When to Seek Them

Any breastfeeding mother who has concerns about potential exposures should consider diagnostic evaluation. This is especially important for mothers who work with chemicals or hazardous materials, those taking medications, mothers with infectious diseases, or those living in environments where they may encounter environmental toxins. Healthcare providers should maintain a high level of awareness about the vulnerability of infants and the importance of identifying potential risks early.^[1]

Breastfeeding mothers should seek diagnostic testing when they have been exposed to occupational hazards such as chemotherapy drugs, dry cleaning solvents, laboratory chemicals, or ionizing radiation. Employers are required to provide information about chemical exposures to all workers, including breastfeeding mothers, and should help reduce exposure to harmful substances as much as possible.^[2]

Environmental exposures represent another important reason to consider diagnostic evaluation. Mothers who may have encountered substances like asbestos, certain pesticides, or PFAS (man-made chemicals used in non-stick cookware and water-repellent products) should discuss testing options with their healthcare provider. Lead exposure is particularly concerning, as mothers can pass lead to their infants through breast milk, potentially causing long-term effects on the child’s neurodevelopment. No safe blood lead level has been identified for children.^[13]

Mothers with infectious illnesses should also seek guidance about diagnostic testing. The decision to continue breastfeeding during an infection requires balancing the protective benefits of breast milk against the risk of transmitting a clinically significant infection to the infant. Fear and uncertainty about infections often lead healthcare providers to recommend stopping breastfeeding out of caution, which can deprive the infant of protective, nutritional, and emotional benefits exactly when they are most needed.^[3]

Women taking medications while breastfeeding should consult with their healthcare provider about whether diagnostic monitoring is needed. Almost any medicine taken by mouth passes into breast milk to some degree, though usually in very small amounts. The risk to the infant varies depending on factors like the baby’s age, health status, and how much breast milk they consume.^[5]

Diagnostic Methods for Identifying Exposures

Blood Testing for Chemical and Environmental Exposures

Blood tests are one of the primary diagnostic tools used to measure exposure to harmful substances. Blood lead level (BLL) testing is particularly important for breastfeeding mothers who may have been exposed to lead. Healthcare providers measure lead in micrograms per deciliter, and specific recommendations exist based on the results. If a pregnant or breastfeeding woman has a BLL of 5 micrograms per deciliter or higher, the provider should work to identify the source of exposure, often collaborating with local health departments and occupational medicine specialists.^[13]

For mothers with BLLs between 5 and 39 micrograms per deciliter, breastfeeding can continue, but the infant’s blood lead levels should be monitored regularly. If the infant’s levels remain below 5 micrograms per deciliter, breastfeeding can safely continue. However, when infant levels rise or fail to decline, and the mother’s BLL is 20 or higher while the infant’s is 5 or higher, breast milk may be the source of exposure. In these cases, mothers should consider temporarily pumping and discarding their milk until their own levels decrease.^[13]

Blood testing can also detect other environmental chemicals. For substances like PFAS, which accumulate in body tissues by binding to proteins, blood tests help determine exposure levels. However, given current scientific understanding, the benefits of breastfeeding still outweigh potential risks from PFAS exposure through breast milk.^[1]

Testing for Infectious Diseases

Documenting the transmission of infection from mother to infant through breastfeeding requires a systematic approach. The first step involves establishing the occurrence of a specific infection in the mother, either through clinical signs or laboratory confirmation. Healthcare providers must demonstrate that the infectious agent persists in a way that could allow transmission to the infant.^[3]

Isolation or identification of the infectious agent from breast milk or from an infectious lesion on the breast is important evidence, though not absolute proof of transmission. Laboratory testing may involve culturing samples to grow and identify specific bacteria or viruses, or using molecular techniques to detect genetic material from pathogens. Epidemiologic evidence must also be considered, including matching characteristics of organisms isolated from the infant to those found in the mother.^[9]

For certain infections, specific testing protocols exist. Routine prenatal care in the United States includes laboratory testing for sexually transmitted infections and HIV. Most women living with HIV are identified before or during their maternity hospital stay. For mothers with HIV who are on antiretroviral therapy and maintain an undetectable viral load, the risk of transmission through breastfeeding is less than one percent.^[8]

Testing for hepatitis B and C viruses may be recommended in certain situations. These viruses cannot spread through breastfeeding or close contact unless there is exposure to blood. Testing helps determine whether precautions are needed, though breastfeeding itself is not typically contraindicated for mothers with these infections.^[8]

Medication Monitoring

When breastfeeding mothers take medications, diagnostic monitoring focuses on ensuring the drug is safe for the infant. Healthcare providers consider multiple factors before recommending testing. The infant’s health and age significantly affect how medications in breast milk impact them. Exposure to medicine in breast milk poses the highest risk to premature babies, newborns, and babies with kidney or other health problems. In contrast, the risk is lowest for babies who are six months or older and generally healthy, as their bodies are better able to process medications.^[5]

The amount of medication that reaches the infant depends on several measurable factors. The concentration of the drug in the mother’s blood, the volume of milk consumed, and how well the infant’s digestive system absorbs the medication all play roles. Medications with certain properties are considered safer, including those that are highly bound to proteins in the blood, have a low ratio of drug concentration between blood and milk, and have shorter half-lives in the body.^[7]

In general, less than one percent of a medication taken by the mother will pass through breast milk to the baby. Modern technology can detect very small amounts of drugs in milk and blood plasma, but their detection does not necessarily mean they will cause harm. Most medications are unlicensed for use during breastfeeding simply because manufacturers have not conducted research to confirm safety, not because evidence shows they are dangerous.^[7]

Breast Milk Testing

Direct testing of breast milk for substances is possible but not always recommended. For lead exposure specifically, testing breast milk for lead is not advised. Instead, monitoring the mother’s blood lead level and the infant’s blood lead level provides more useful information for making decisions about breastfeeding safety.^[13]

Scientists often test breast milk samples when studying environmental chemical exposures in populations. These studies help researchers understand which chemicals appear in breast milk and at what levels. However, finding a chemical in breast milk during research does not automatically mean it poses a health risk to infants or that breastfeeding should stop.^[14]

In accidental exposure situations, such as when a mother may have been exposed to chemical or biological agents, breast milk may be analyzed depending on the specific circumstances. This is particularly relevant in occupational settings where mothers work with laboratory chemicals, dry cleaning solvents containing perchloroethylene (PCE), or chemotherapy drugs. Studies have shown that PCE can enter breast milk when mothers are exposed, with greater amounts found in milk when exposure to higher levels occurs over longer periods.^[2]

Distinguishing Sources of Infant Exposure

An important part of diagnostic evaluation involves determining whether breast milk is actually the source of an infant’s exposure to a harmful substance or infection. This requires excluding other possible routes of transmission. Infants can be exposed to infections through airborne transmission, droplets, direct contact with infected fluids, or from other people or animals. They can also acquire infections before birth through the placenta or during delivery.^[3]

For chemical exposures, infants may encounter substances in their environment directly, rather than only through breast milk. For example, infants can be exposed to lead from deteriorating paint, contaminated soil, or contaminated water. Environmental assessment by local health departments can help identify such sources. Only after ruling out these alternative exposures can breast milk be confirmed as the source.^[13]

Diagnostics for Clinical Trial Qualification

Information about specific diagnostic criteria used to qualify breastfeeding mothers for clinical trials related to exposure via breast milk is limited in the available sources. However, the general principles of diagnostic testing apply when researchers design studies to evaluate exposures or interventions in breastfeeding populations.

Clinical trials examining medications in breastfeeding women would typically require confirmation that participants are actively breastfeeding and documentation of the infant’s age, health status, and how much breast milk they consume. Baseline blood tests of both mother and infant might establish starting levels of the medication or substance being studied. Ongoing monitoring would track levels in maternal blood, breast milk if relevant to the research question, and infant blood to understand transfer and effects.^[10]

Studies evaluating environmental or occupational exposures would need diagnostic confirmation of the exposure in question. This might include workplace monitoring data, environmental sampling results, and baseline biological testing of mothers and infants. Follow-up diagnostics at defined intervals would document changes over time and help researchers understand the relationship between maternal exposure levels and infant outcomes.^[4]

For infectious disease studies, enrollment would require laboratory confirmation of the maternal infection using standard diagnostic techniques appropriate for the specific pathogen. Serial testing of both mother and infant would be necessary to document whether transmission occurs through breastfeeding versus other routes. This might include viral load testing, antibody testing, and attempts to isolate the infectious agent from breast milk samples.^[9]